Literature DB >> 12788080

Parathyroid hormone induces the nuclear orphan receptor NOR-1 in osteoblasts.

Flavia Q Pirih1, Jeanne M Nervina, Lee Pham, Tara Aghaloo, Sotirios Tetradis.   

Abstract

Parathyroid hormone (PTH) significantly affects osteoblast function by altering gene expression. We have identified neuron-derived orphan receptor-1 (NOR-1) as a PTH-induced primary gene in osteoblastic cells. NOR-1, Nurr1, and Nur77 comprise the NGFI-B nuclear orphan receptor family and Nurr1 and Nur77 are PTH-induced primary osteoblastic genes. Ten nM PTH maximally induced NOR-1 mRNA at 2h in primary mouse osteoblasts and at 1h in mouse calvariae. Cycloheximide pretreatment did not inhibit PTH-induced NOR-1 mRNA. PTH activates cAMP-protein kinase A (PKA), protein kinase C (PKC), and calcium signaling. Forskolin (PKA activator) and PMA (PKC activator) mimicked PTH-induced NOR-1 mRNA. Ionomycin (calcium ionophore) and PTH(3-34), which do not activate PKA, failed to induce NOR-1 mRNA. PKA inhibition with H89 blocked PTH- and FSK-induced NOR-1 mRNA. PMA pretreatment to deplete PKC inhibited PMA-induced, but not PTH-induced, NOR-1 mRNA. We conclude that NOR-1 is a PTH-regulated primary osteoblastic gene that is induced mainly through cAMP-PKA signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788080     DOI: 10.1016/s0006-291x(03)00931-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.

Authors:  Yanbin Liang; Chen Li; Victor M Guzman; William W Chang; Albert J Evinger; Jozelyn V Pablo; David F Woodward
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

2.  The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation.

Authors:  Takashi Nomiyama; Takafumi Nakamachi; Florence Gizard; Elizabeth B Heywood; Karrie L Jones; Naganari Ohkura; Ryuzo Kawamori; Orla M Conneely; Dennis Bruemmer
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

Review 3.  Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.

Authors:  Michael A Pearen; George E O Muscat
Journal:  Mol Endocrinol       Date:  2010-04-14

4.  Conditional disruption of IGF-I gene in type 1α collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading.

Authors:  Chandrasekhar Kesavan; Jon E Wergedal; K-H William Lau; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-30       Impact factor: 4.310

5.  Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation.

Authors:  Flavia Q Pirih; Rosette Abayahoudian; David Elashoff; Farhad Parhami; Jeanne M Nervina; Sotirios Tetradis
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

Review 6.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

7.  Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.

Authors:  Michael S Huang; Sean Morony; Jinxiu Lu; Zina Zhang; Olga Bezouglaia; Wendy Tseng; Sotirios Tetradis; Linda L Demer; Yin Tintut
Journal:  J Biol Chem       Date:  2007-05-22       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.